Implementation expectations of eCTD 4.0
Key Concepts Behind eCTD 4.0 and their Impact on Product Submissions
The Drivers and Benefits behind eCTD 4.0
The EMA prepares itself for Brexit
The Chinese Food & Drug Administration moves to eCTD
EMA Officially Endorses the New EudraVigilance System for Adverse Reactions
Why we believe in IDMP, and you should too
EXTEDO Opens New Office in Shanghai
EXTEDO上海分公司成立!
Health Canada confirms mandatory use of eCTD format from 1st January 2018
eRA 2017 - A first-timers impressions
Overview of the New Requirements for Electronic Submission of Drug Master Files (DMFs)